Saturday 17 October 2026
Export BYSI’s income statement to Excel — free account
BeyondSpring Inc.
BYSI Healthcare Biotechnology
In the quarter to June 2026, EPS grew 50.0% and free cash flow grew 35.8%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
0.56
0.02
−3.45%
Follow BYSI
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
0.46 | 0.64 | 0.93 | 0.98 | |
Current Ratio |
0.70 | 1.09 | 1.54 | 1.89 | |
Net Debt/EBITDA |
3.81 | 3.55 | 4.56 | 7.39 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
4.44 | 1.52 | 2.58 | 2.72 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.09) | (0.08) | (0.14) | (0.10) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.09) | (0.08) | (0.14) | (0.10) | |
Cash per Share |
0.16 | 0.19 | 0.31 | 0.31 | |
Shareholders Equity per Share |
(0.88) | (0.74) | (0.59) | (0.49) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.88) | (0.74) | (0.59) | (0.49) | |
Free Cash Flow |
(3.77) | (3.28) | (5.50) | (4.19) | |
Working Capital |
(4.29) | 1.13 | 7.31 | 11.52 | |
Capital Expenditures |
— | — | 0.00 | 0.00 | |
Net Current Asset Value |
(40.73) | (35.26) | (29.04) | (24.88) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
— | — | 0.00 | 0.00 | |
| Other line items | |||||
Average Payables |
0.53 | 0.50 | 0.33 | 1.21 | |
Average Assets |
22.82 | 27.76 | 30.12 | 25.19 | |
Average Common Equity |
(26.78) | (21.51) | (19.14) | (29.18) |
Columns are period end dates